Imagion Biosystems has raised AU$3.75M to fund the commencement of a Phase 2 clinical trial for its MagSense® imaging agent. The funding follows the FDA's clearance of their IND application. The raise was led by CPS Capital Group Pty Ltd. Patient recruitment for the trial is expected to begin later this year.
Who to call at Imagion Biosystems, and when
A new round usually means Imagion Biosystems is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Imagion Biosystems raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Imagion Biosystems, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Imagion Biosystems
Location
Melbourne, Victoria, Australia
About
Imagion Biosystems is a clinical-stage imaging company pioneering a new category of MRI technology that changes suspicion into certainty. The company has developed and is advancing clinical applications for MagSense®, a first-of-its-class MRI imaging agent that enables clinicians to detect cancer earlier and with greater precision. Advancing molecular MRI, the company uses non-radioactive, bio-safe magnetic nanoparticles to improve diagnostic certainty for a broad range of applications, including HER2+ breast cancer, prostate cancers, and ovarian cancers.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Imagion Biosystems raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
MelbourneBiotechnologyHealth CareMedicalMedical DeviceTherapeuticsHealth Diagnostics